Rankings
▼
Calendar
ALGS Q4 2023 Earnings — Aligos Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ALGS
Aligos Therapeutics, Inc.
$45M
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
-24.2% YoY
Gross Profit
$3M
100.0% margin
Operating Income
-$26M
-969.7% margin
Net Income
-$28M
-1040.4% margin
EPS (Diluted)
$-1.12
QoQ Revenue Growth
-17.2%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$152M
Total Liabilities
$59M
Stockholders' Equity
$92M
Cash & Equivalents
$136M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$4M
-24.2%
Gross Profit
$3M
$4M
-24.2%
Operating Income
-$26M
-$23M
-14.6%
Net Income
-$28M
-$22M
-27.4%
← FY 2023
All Quarters
Q1 2024 →